NCT03284697

Brief Summary

Aim of the study was to evaluate and compare clinical and radiographic success with MTA and calcium hydroxide as direct pulp capping materials in cariously exposed mandibular molars. Study was conducted in Post Graduate Institute of Dental Sciences, Rohtak in department of Conservative Dentistry \& Endodontics. Mature permanent mandibular molars with reversible pulpitis exhibiting occlusal pulp exposure from primary dental caries were included in the study. After excavation of caries and obtaining pulpal hemostasis, patients were randomly allocated into two groups- MTA and Calcium Hydroxide. Pulp was capped with respective allocated material and then tooth in both groups were restored according to standard protocol.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 15, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2017

Completed
Last Updated

January 12, 2018

Status Verified

January 1, 2018

Enrollment Period

1.1 years

First QC Date

September 8, 2017

Last Update Submit

January 11, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluate and compare the clinical and radiographic success with MTA and calcium hydroxide as direct pulp capping materials.

    CRITERIA FOR SUCCESSFUL OUTCOME * A positive vitality test. * No pain on percussion. * No widening of periodontal ligament on periapical radiograph. * No clinical or radiographic signs and/or symptoms of irreversible pulpitis and pulp necrosis. CRITERIA FOR FAILURE * No response to pulp vitality test. * Teeth exhibiting clinical or radiographic signs and/or symptoms of irreversible pulpitis and pulp necrosis.

    Baseline to 1 year

Secondary Outcomes (1)

  • To assess the pain intensity before and after the direct pulp capping with visual analog scale (VAS).

    Baseline to 7 days

Study Arms (2)

DPC with Ca(OH)2

ACTIVE COMPARATOR

Direct pulp capping with Ca(OH)2.

Procedure: Direct Pulp Capping with Ca(OH)2

DPC with MTA

ACTIVE COMPARATOR

Direct pulp capping with MTA

Procedure: Direct Pulp Capping With MTA

Interventions

Calcium hydroxide powder was mixed with saline and placed over the exposed pulp tissue. The cavities were then restored with resin modified GIC liner followed by composite restoration.

Also known as: Vital Pulp Therapy
DPC with Ca(OH)2

MTA was mixed using1:3 water/ powder ratio and applied to exposure site. Then cotton pellets soaked in normal saline was placed over MTA and cavity was sealed provisionally with IRM. After 24 hours, the patient was recalled and the cavity was restored with resin modified GIC liner followed by composite restoration.

Also known as: Vital pulp therapy
DPC with MTA

Eligibility Criteria

Age15 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patient willing to participate in the study.
  • Age group- 15-40 years.
  • Mature permanent mandibular molars with reversible pulpitis.
  • Teeth exhibiting occlusal pulp exposure from primary dental caries.

You may not qualify if:

  • Primary teeth.
  • Teeth with irreversible pulpitis (spontaneous pain) or pulp necrosis, chronic periodontitis, cracked tooth, internal or external resorption, calcified canals, associated with sinus tract, and furcation or apical radiolucency.
  • Immuno-compromised, diabetic, pregnant and hypertensive patients.
  • Positive history of antibiotic and analgesic use within past one month of the treatment.
  • Failure to obtain authorization from patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Pemetrexed

Intervention Hierarchy (Ancestors)

GuanineHypoxanthinesPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsGlutamatesAmino Acids, AcidicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, Dicarboxylic

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal

Study Record Dates

First Submitted

September 8, 2017

First Posted

September 15, 2017

Study Start

October 14, 2016

Primary Completion

November 30, 2017

Study Completion

November 30, 2017

Last Updated

January 12, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share